• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72KIT
Medical Device Problem Codes Break (1069); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/10/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.
 
Event or Problem Description
The patient was undergoing a thrombectomy procedure in the middle cerebral artery (mca) using a penumbra system red72 reperfusion catheter (red72), a non-penumbra microcatheter, and a non-penumbra sheath.During the procedure, the physician made one pass using the red72.Subsequently, while advancing the red72 past the carotid t to make the next pass, the physician experienced resistance and decided to retract the red72.However, upon retracting, the physician noticed the midshaft towards the distal end of the red72 had broken off under angiography.Therefore, the physician used a snare device to remove the broken piece of the red72 out from the patient.The procedure was completed using a non-penumbra catheter, non-penumbra stent retriever, and the same sheath.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Evaluation of the returned red72 confirmed a fracture on the distal shaft.Evaluation revealed that the red72 was stretched proximal to the fractured location.This indicated that the device was stretched prior to fracture.This damage typically occurs due to being retracted against resistance.If the device is retracted against resistance, it may become stretched and subsequently fracture.The root cause of the resistance experienced during the procedure could not be determined.Further evaluation revealed kinks on the catheter shaft.This damage was likely incidental to the reported complaint.The distal fractured segment was not returned for evaluation.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER
Common Device Name
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key16092696
Report Number3005168196-2022-00617
Device Sequence Number6651576
Product Code NRY
UDI-Device Identifier00815948023932
UDI-Public815948023932
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
K211654
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/24/2023
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/29/2025
Device Catalogue NumberRED72KIT
Device Lot NumberH12878
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/11/2022
Supplement Date Received by Manufacturer12/28/2022
Initial Report FDA Received Date01/04/2023
Supplement Report FDA Received Date01/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/30/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexFemale
Date Report Sent to FDA01/01/2005
-
-